Plexus Corp. (NASDAQ:PLXS) Receives $162.33 Consensus Target Price from Brokerages

Shares of Plexus Corp. (NASDAQ:PLXS) have received an average recommendation of “Moderate Buy” from the four analysts that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $163.00.

Several research firms have recently commented on PLXS. KeyCorp began coverage on Plexus in a research note on Tuesday, October 22nd. They issued a “sector weight” rating for the company. Needham & Company LLC upped their target price on shares of Plexus from $162.00 to $172.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Stifel Nicolaus assumed coverage on shares of Plexus in a report on Tuesday. They issued a “hold” rating and a $152.00 target price for the company. Benchmark reaffirmed a “buy” rating and issued a $165.00 target price on shares of Plexus in a report on Wednesday, January 22nd. Finally, StockNews.com raised shares of Plexus from a “hold” rating to a “buy” rating in a report on Monday, November 18th.

Insider Buying and Selling at Plexus

In other Plexus news, CEO Todd P. Kelsey sold 1,500 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $156.39, for a total transaction of $234,585.00. Following the completion of the transaction, the chief executive officer now owns 74,271 shares of the company’s stock, valued at $11,615,241.69. This represents a 1.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Michael J. Running sold 539 shares of the stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $155.87, for a total transaction of $84,013.93. Following the transaction, the insider now directly owns 1,030 shares of the company’s stock, valued at $160,546.10. This trade represents a 34.35 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,239 shares of company stock valued at $2,212,730 in the last 90 days. Insiders own 1.76% of the company’s stock.

Institutional Trading of Plexus

Hedge funds have recently made changes to their positions in the business. Quarry LP raised its position in shares of Plexus by 573.5% during the 3rd quarter. Quarry LP now owns 229 shares of the technology company’s stock valued at $31,000 after buying an additional 195 shares in the last quarter. R Squared Ltd purchased a new stake in shares of Plexus during the 4th quarter valued at about $45,000. Point72 DIFC Ltd purchased a new stake in shares of Plexus during the 3rd quarter valued at about $51,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Plexus during the 3rd quarter valued at about $55,000. Finally, USA Financial Formulas purchased a new stake in Plexus in the 4th quarter worth about $56,000. 94.45% of the stock is currently owned by hedge funds and other institutional investors.

Plexus Trading Up 1.5 %

NASDAQ:PLXS opened at $142.39 on Thursday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.53 and a quick ratio of 0.70. The firm has a market capitalization of $3.86 billion, a price-to-earnings ratio of 33.04 and a beta of 0.89. Plexus has a one year low of $90.18 and a one year high of $172.89. The business has a fifty day moving average price of $159.43 and a 200-day moving average price of $143.56.

Plexus (NASDAQ:PLXS) last posted its quarterly earnings data on Wednesday, January 22nd. The technology company reported $1.49 EPS for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a return on equity of 10.36% and a net margin of 3.03%. Sell-side analysts forecast that Plexus will post 5.97 EPS for the current year.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.